目的观察HA中性大孔树脂血浆吸附治疗重型肝炎肝性脑病的治疗效果，探讨肝性脑病新的治疗方法。
Objectives: the aim of this study is to evaluate the therapeutic effectiveness of plasma adsorption with ha microporous resin in patients of severe hepatitis with hepatic encephalopathy.
目的评价纳络酮治疗肝硬化肝性脑病的疗效。
Objective To assess the curative effect of hepatic cerebropathy with naloxone.
目的观察复合辅酶治疗肝性脑病的临床疗效。
Objective To observe the efficacy of coenzyme complex in treating hepatic encephalopathy.
治疗方法的选择及目的依据肝性脑病的程度而定。
Treatment options and goals depend on the acuity of hepatic encephalopathy.
目的观察左旋门冬氨酸-鸟氨酸治疗肝硬化合并肝性脑病的临床疗效。
Objective To observe the therapeutic effects of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy.
对于PVT的治疗外科血栓切除术不是首选治疗方法，因为它具有侵入性，技术上存在困难并且易引起肝性脑病。
Surgical thrombectomy is not preferred as treatment method for PVT since it is invasive, technically difficult and can cause hepatic encephalopathy.
Sharma博士：我认为联合应用应该作为肝性脑病的首选治疗，这是有试验数据支持的。
Dr Sharma: I think their combination should be used for the primary treatment of he and there is data which backs up this case.
Sharma博士：目前我们应用非吸收性双糖——例如乳糖醇或乳果糖，以及肠道吸收较少的抗生素来治疗肝性脑病。
Dr Sharma: Currently we are using either non-absorbable disaccharides such as lactitol or lactulose as well as antibiotics which are poorly absorbed from the gut.
目的观察纳洛酮治疗肝硬化合并肝性脑病的疗效。
Objective To observe the effect of naloxone on cirrhotic patients with hepatic encephalopathy (HE).
Sharma博士：在Bass等人进行的该项研究之前，已经有很多研究表明利福昔明治疗肝性脑病有效。
Dr Sharma: Even before this study by Bass et al there were a number of studies which showed that rifaximin is relatively efficacious in treating he.
本发明公开了一种治疗肝病及其所伴肝性脑病的药物。
The present invention discloses one kind of medicine for treating hepatic diseases and hepatic encephalopathy.
目的：观察门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床疗效及安全性。
Objective: To evaluate the effect and safety of L-ornithine-L-aspartate on Subclinical Hepatic Encephalopathy.
目的：观察门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床疗效及安全性。
Objective: To evaluate the effect and safety of L-ornithine-L-aspartate on Subclinical Hepatic Encephalopathy.
应用推荐